Literature DB >> 23154766

Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count.

Volkan Adsay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23154766     DOI： 10.1097/PAS.0b013e318272ff77

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN： 0147-5185            Impact factor:   6.394


× No keyword cloud information.
  25 in total

Review 1.  Pathology of Neuroendocrine Tumours of the Female Genital Tract.

Authors:  Brooke E Howitt; Paul Kelly; W Glenn McCluggage
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

Review 2.  Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Günter Klöppel; Stefano La Rosa
Journal:  Virchows Arch       Date:  2017-11-13       Impact factor: 4.064

Review 3.  Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.

Authors:  Hiroki Tanaka; Shimpei Matsusaki; Youichirou Baba; Yoshiaki Isono; Hiroaki Kumazawa; Tomohiro Sase; Hiroshi Okano; Tomonori Saito; Katsumi Mukai; Hiroshi Kaneko
Journal:  Clin J Gastroenterol       Date:  2015-10-06

4.  Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.

Authors:  Trynda N Kroneman; Jesse S Voss; Christine M Lohse; Tsung-Teh Wu; Thomas C Smyrk; Lizhi Zhang
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

5.  Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Authors:  R García-Carbonero; F Vilardell; P Jiménez-Fonseca; R González-Campora; E González; M Cuatrecasas; J Capdevila; I Aranda; J Barriuso; X Matías-Guiu
Journal:  Clin Transl Oncol       Date:  2013-06-08       Impact factor: 3.405

6.  Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?

Authors:  Federica Grillo; Manuela Albertelli; Francesca Annunziata; Mara Boschetti; Andrea Caff; Simona Pigozzi; Diego Ferone; Luca Mastracci
Journal:  Endocrine       Date:  2015-09-11       Impact factor: 3.633

7.  Reliability of Ki-67 Determination in FNA Samples for Grading Pancreatic Neuroendocrine Tumors.

Authors:  Cristina Díaz Del Arco; J Ángel Díaz Pérez; Luis Ortega Medina; Javier Sastre Valera; M Jesús Fernández Aceñero
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

8.  Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.

Authors:  Ozgur Mete; Arthur S Tischler; Ronald de Krijger; Anne Marie McNicol; Graeme Eisenhofer; Karel Pacak; Shereen Ezzat; Sylvia L Asa
Journal:  Arch Pathol Lab Med       Date:  2014-02       Impact factor: 5.534

Review 9.  [Grading of neuroendocrine tumors].

Authors:  W Saeger; P A Schnabel; P Komminoth
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

10.  Cytopathological evaluation of potential malignancy of duodenal gastrinoma using aspiration smears from two patients' resected tumors (NET G1, NET G2): A case report.

Authors:  Hirotaka Noda; Kazuyoshi Masuda; Masami Kanbara; Hiromi Maeda; Tadao K Kobayashi; Chikao Yutani
Journal:  Mol Clin Oncol       Date:  2020-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.